查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1702369

全球球囊瓣膜成形术器械市场 - 2025 年至 2033 年

Global Balloon Valvuloplasty Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 165 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球气球瓣膜成形术设备市场规模达到 20.3 亿美元，预计到 2033 年将达到 39.5 亿美元，在 2025-2033 年预测期内的复合年增长率为 6.8%。

球囊瓣膜成形术装置是用于治疗瓣膜狭窄（心臟瓣膜变窄）的医疗设备。它们可以扩大瓣膜开口、改善血液流动并减轻症状。它们通常用于介入性心臟病学，以缓解症状、缩短恢復时间并减少住院时间。

市场动态：

驾驶员和约束装置

心臟瓣膜疾病盛行率上升

全球球囊瓣膜成形术设备市场受到心臟瓣膜疾病盛行率不断上升的推动，例如主动脉瓣狭窄、二尖瓣狭窄和肺动脉瓣疾病。人口老化和高血压、糖尿病、肥胖和吸烟等生活方式相关的风险因素进一步加剧了这些状况。球囊瓣膜成形术是外科瓣膜置换术的一种微创替代方法，具有住院时间短、恢復时间快、术后併发症少等优点。

例如，全球心血管疾病－心臟瓣膜疾病在全球呈现上升趋势，其中最常见的是风湿性心臟病，影响4,100万人，在发展中国家的发病率不断上升。这是由于年轻成年人口的增长以及抗生素、微生物检测和超音波心动图技术的普及，从而降低了过早死亡率。

再狭窄和手术併发症的风险

全球球囊瓣膜成形术设备市场因再狭窄和其他手术併发症而面临挑战。再狭窄，即手术后治疗瓣膜再次变窄，通常需要重复干预，对患者和医疗保健系统造成负担。这在老年患者或钙化严重的患者中尤其明显，因为这种手术的效果可能是暂时的。

其他风险包括血管併发症、栓塞、心律不整和瓣膜逆流，导致患者预后不良。由于可能出现併发症，医疗保健提供者不愿广泛采用该手术，尤其是在有更耐用的替代方案（如手术瓣膜置换）可用的情况下。经导管主动脉瓣置换术（TAVR）等替代治疗方案的可用性也可能限制球囊瓣膜成形术设备市场的成长。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第二章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的程式码片段
  • 按应用程式截取的程式码片段
  • 按年龄分类的片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第三章：动态

  • 影响因素
    • 驱动程式
      • 心臟瓣膜疾病盛行率上升
      • 科技进步的崛起
    • 限制
      • 再狭窄和手术併发症的风险
      • 设备成本高
    • 机会
      • 新兴市场的扩张
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第五章：依产品类型

  • 标准气球
  • 切割气球
  • 得分气球
  • 高压气球
  • 低压气球

第六章：按应用

  • 主动脉瓣狭窄
  • 肺动脉瓣狭窄

第七章：依年龄组

  • 儿科
  • 成人

第 8 章：按最终用户

  • 医院
  • 门诊手术中心
  • 专科诊所
  • 其他的

第九章：区域市场分析与成长机会

  • 北美洲
    • 关键区域特定动态
      • 我们
      • 加拿大
      • 墨西哥
  • 欧洲
    • 关键区域特定动态
      • 德国
      • 英国
      • 法国
      • 西班牙
      • 义大利
      • 欧洲其他地区
  • 拉丁美洲
    • 关键区域特定动态
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地区
  • 亚太
    • 关键区域特定动态
      • 中国
      • 印度
      • 日本
      • 韩国
      • 亚太其他地区
  • 中东和非洲
    • 关键区域特定动态

第十章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 11 章：公司简介

  • Medtronic
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 併购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT分析
  • Balton
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Cardinal Health, Inc
  • Cook Medical Inc
  • Terumo Corporation
  • Becton, Dickinson and Company (BD)
  • TORAY MEDICAL CO,. LTD.
  • BVM Medical

第 12 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章：附录

简介目录
Product Code: MD9460

The global balloon valvuloplasty devices market reached US$ 2.03 billion in 2024 and is expected to reach US$ 3.95 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033.

Balloon valvuloplasty devices are medical devices used to treat valvular stenosis, a narrowing of heart valves. They widen the valve opening, improve blood flow, and reduce symptoms. They're commonly used in interventional cardiology for symptom relief, shorter recovery times, and reduced hospitalization duration.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Valvular Heart Diseases

The global balloon valvuloplasty devices market is driven by the increasing prevalence of valvular heart diseases, such as aortic stenosis, mitral stenosis, and pulmonary valve disorders. The aging population and lifestyle-related risk factors like hypertension, diabetes, obesity, and smoking further exacerbate these conditions. Balloon valvuloplasty is a minimally invasive alternative to surgical valve replacement, offering benefits like shorter hospital stays, faster recovery times, and reduced post-operative complications.

For instance, valvular heart disease, a global cardiovascular disease, is increasing globally, with rheumatic heart disease, the most common, affecting 41 million people, increasing in developing nations. This is due to the growth of the young adult population and improved access to antibiotics, microbiological testing, and echocardiography, which have reduced premature mortality rates.

Risk of Restenosis and Procedural Complications

The global balloon valvuloplasty devices market faces challenges due to restenosis and other procedural complications. Restenosis, the re-narrowing of the treated valve after the procedure, often requires repeat interventions, burdening patients and healthcare systems. This is particularly evident in elderly patients or those with severe calcification, where the procedure's effectiveness may be temporary.

Other risks include vascular complications, embolization, arrhythmias, and valve regurgitation, leading to adverse patient outcomes. The potential for complications makes healthcare providers hesitant to adopt the procedure widely, especially when more durable alternatives like surgical valve replacement are available. The availability of alternative treatment options, such as transcatheter aortic valve replacement (TAVR), may also limit the growth of the balloon valvuloplasty devices market.

Segment Analysis

The global balloon valvuloplasty devices market is segmented based on product type, application, age group, end user, and region.

Product Type:

The standard balloon from product type segment is expected to dominate the balloon valvuloplasty devices market with the highest market share

Standard balloons are medical devices used in balloon valvuloplasty to dilate narrowed heart valves, restoring blood flow in patients with valvular stenosis. These high-strength balloons, available in various sizes and diameters, are delivered via catheter-based systems and inflated to break calcific deposits, improving valve function in high-risk patients not candidates for open-heart surgery.

The balloon valvuloplasty devices market is growing due to the increasing prevalence of valvular heart diseases, preference for minimally invasive procedures, technological advancements, expanding healthcare infrastructure, and government initiatives. Benefits include reduced hospital stays, faster recovery times, and fewer post-operative complications. Technological advancements and improved access to interventional cardiology in developing regions further support market growth.

Geographical Analysis

North America is expected to hold a significant position in the balloon valvuloplasty devices market with the highest market share

The North American balloon valvuloplasty devices market is growing due to the increasing prevalence of valvular heart diseases, especially among the aging population. Technological advancements and favorable reimbursement policies are driving innovation. Increased awareness among healthcare professionals and patients, coupled with rising healthcare expenditure and government support for cardiovascular disease management, is expected to further accelerate market growth in North America.

For instance, in January 2025, Concept Medical has enrolled the first patient in its MAGICAL trial, comparing its sirolimus-coated balloon to traditional angioplasty for patients with below-the-knee PDA. The company secured an Investigational Device Exemption from the FDA for the MagicTouch PTA and is launching two more trials to evaluate its drug-coated alternative.

Competitive Landscape

The major global players in the balloon valvuloplasty devices market include Medtronic, Balton, Boston Scientific Corporation, B. Braun Melsungen AG, Cardinal Health, Inc., Cook Medical Inc., Terumo Corporation, Becton, Dickinson and Company (BD), TORAY MEDICAL CO,.LTD., and BVM Medical, among others.

Key Developments

  • In February 2025, Cagent Vascular launched the Serranator SL-PRO percutaneous transluminal angioplasty (PTA) serration balloon catheter for chronic limb-threatening ischaemia and pedal disease. The catheter uses Cagent's proven serration technology on a redesigned platform, offering improved deliverability and trackability. It also offers 1,000 times increase in point force compared to plain balloons and a controlled lumen gain with minimal dissection.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global balloon valvuloplasty devices market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by Age Group
  • 2.6. Snippet by End User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Valvular Heart Diseases
      • 3.1.1.2. Rise in the Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. Risk of Restenosis and Procedural Complications
      • 3.1.2.2. High Cost of Devices
    • 3.1.3. Opportunity
      • 3.1.3.1. Expansion in Emerging Markets
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Standard Balloon*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Cutting Balloon
  • 5.4. Scoring Balloon
  • 5.5. High-Pressure Balloon
  • 5.6. Low-Pressure Balloon

6. By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Aortic Valve Stenosis*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Pulmonary Valve Stenosis

7. By Age Group

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 7.1.2. Market Attractiveness Index, By Age Group
  • 7.2. Pediatric*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Adult

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Specialty Clinics
  • 8.5. Others

9. Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of Latin America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Medtronic*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Balton
  • 11.3. Boston Scientific Corporation
  • 11.4. B. Braun Melsungen AG
  • 11.5. Cardinal Health, Inc
  • 11.6. Cook Medical Inc
  • 11.7. Terumo Corporation
  • 11.8. Becton, Dickinson and Company (BD)
  • 11.9. TORAY MEDICAL CO,. LTD.
  • 11.10. BVM Medical

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us